Anhui Anke Biotechnology (Group) Co., Ltd.

Anhui Anke Biotechnology (Group) Co., Ltd.verified

300009.SZ

Price:

$9.77

Market Cap:

$16.34B

Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohisto...[Read more]

Industry

Biotechnology

IPO Date

2009-10-30

Stock Exchange

SHZ

Ticker

300009.SZ

The Enterprise Value as of December 2025 (TTM) for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) is 16.20B

According to Anhui Anke Biotechnology (Group) Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.20B. This represents a change of 13.03% compared to the average of 14.34B of the last 4 quarters.

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) Historical Enterprise Value (quarterly & annually)

How has 300009.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Anhui Anke Biotechnology (Group) Co., Ltd. over the last ten years is 15.96B. The current 16.20B Enterprise Value has changed 10.05% with respect to the historical average. Over the past ten years (40 quarters), 300009.SZ's Enterprise Value was at its highest in in the June 2021 quarter at 23.86B. The Enterprise Value was at its lowest in in the December 2016 quarter at 10.82B.

Quarterly (TTM)
Annual

Average

15.96B

Median

15.82B

Minimum

11.28B

Maximum

21.15B

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anhui Anke Biotechnology (Group) Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 225.74%

Maximum Annual Enterprise Value = 21.15B

Minimum Annual Increase = -30.80%

Minimum Annual Enterprise Value = 11.28B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202414.29B-13.36%
202316.49B9.81%
202215.02B-29.01%
202121.15B6.80%
202019.80B29.06%
201915.34B21.37%
201812.64B-26.97%
201717.31B53.50%
201611.28B-30.80%
201516.30B225.74%

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) Average Enterprise Value

How has 300009.SZ Enterprise Value performed in the past?

The current Enterprise Value of Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

15.26B

5-year avg

17.35B

10-year avg

15.96B

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) Enterprise Value vs. Peers

How is 300009.SZ’s Enterprise Value compared to its peers?

Anhui Anke Biotechnology (Group) Co., Ltd.’s Enterprise Value is less than Yunnan Botanee Bio-Technology Group Co.LTD (16.58B), less than Mabwell (Shanghai) Bioscience Co., Ltd. (16.71B), less than DaShenLin Pharmaceutical Group Co., Ltd. (25.81B), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (12.68B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.51B), less than Inner Mongolia Furui Medical Science Co., Ltd. (18.76B), less than Apeloa Pharmaceutical Co.,Ltd (18.68B), greater than Tonghua Dongbao Pharmaceutical Co., Ltd. (15.59B), greater than Tibet Cheezheng Tibetan Medicine Co., Ltd. (13.61B), greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (14.04B),

Build a custom stock screener for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anhui Anke Biotechnology (Group) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anhui Anke Biotechnology (Group) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Anhui Anke Biotechnology (Group) Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?

What is the 3-year average Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?

What is the 5-year average Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?

How does the current Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) compare to its historical average?